Delivery Order SPE2DR25D1004-SPE2DR26FSXT7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,329.91. This non-competitive, firm fixed-price delivery order was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $1,749.44 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL insulin pens (3 mL). The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,781.10. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $6,033.64 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,486.60 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The contract is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,111.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on November 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,607.96 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This was a competitively awarded, non-set-aside firm fixed price contract with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSXT7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,093.27 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL insulin pens. This competitively awarded, firm fixed-price contract was issued on January 8, 2026, with an ultimate completion date of January 9, 2026. The pharmaceutical products will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The IDC serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Cencora, Inc. holds this single-award contract to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The Tresiba insulin product being delivered under this task order supports diabetes management requirements within the Defense Health Agency and broader military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/7/26 |